Impiego di granisetron per os nell'emesi da radioterapia

Keyphrases

• Granisetron 100%
• Emesis 100%
• Radiotherapy-induced 100%
• Radiotherapy 50%
• Radiation Effects 50%
• Dopamine Antagonist 50%
• Pelvis 50%
• Vomiting 50%
• Nausea 50%
• Abdomen 33%
• Chemotherapy 33%
• Adverse Events 33%
• Performance Status 33%
• Wide-field 33%
• Dose Fractionation 33%
• Half-body Irradiation 33%
• Testicle 16%
• Irradiation 16%
• Hodgkin Lymphoma 16%
• X-ray 16%
• Complete Remission 16%
• Iliac 16%
• Radiation Dose 16%
• First Week 16%
• Recto 16%
• Prostate Carcinoma 16%
• Radiation Field 16%
• Conventional Fractionation 16%
• Concomitant Pathology 16%
• High Efficacy 16%
• Total-body 16%
• Metoclopramide 16%
• Linear Accelerator (LINAC) 16%
• Sigmoid Adenocarcinoma 16%
• Seminoma 16%
• Cervical Carcinoma 16%
• 5-HT3 Receptor 16%
• Irradiation Field 16%
• 5-HT3 Antagonist 16%
• Immediate Remission 16%
• Status Anxiety 16%
• Total Body Irradiation 16%
• Lung Carcinoma 16%

Medicine and Dentistry

• Granisetron 100%
• Radiation Therapy 100%
• Pelvis 50%
• Radiation Induced Emesis 50%
• Dopamine Antagonist 50%
• Nausea and Vomiting 50%
• Adverse Event 33%
• Testes 16%
• Hodgkin's Lymphoma 16%
• Lung Carcinoma 16%
• Metoclopramide 16%
• Seminoma 16%
• Serotonin 3 Receptor 16%
• Uterine Cervix Carcinoma 16%
• Colon Adenocarcinoma 16%
• Prostate Adenocarcinoma 16%
• 5-HT3 Antagonist 16%
• Electrocorticography 16%
• Radiation Dose Fractionation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Granisetron 100%
• Dopamine Receptor Blocking Agent 50%
• Nausea and Vomiting 50%
• Radiation Induced Emesis 50%
• Remission 33%
• Chemotherapy 33%
• Adverse Event 33%
• Hodgkin Disease 16%
• Uterine Cervix Carcinoma 16%
• Lung Carcinoma 16%
• Dose Fractionation 16%
• Metoclopramide 16%
• Colon Adenocarcinoma 16%
• Serotonin 3 Antagonist 16%
• Seminoma 16%
• Prostate Adenocarcinoma 16%
• Serotonin 3 Receptor 16%